HeaderImage_10.22.20.png

Event Schedule

october 27, 2020
october 28, 2020
october 29, 2020
vaccinexLogo-1.gif
Novan_Logo.png
Protalix_banner.png
Arch_Logo.png
Outlook_Logo.png
Evofem_Logo.png

Companies

Wednesday, October 28   |   12:00 PM ET

Arch Therapeutics, Inc.

OTCQB: ARTH
Arch_Logo.png

Arch Therapeutics, Inc. is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care.

Wednesday, October 28   |   4:00 PM ET

Navidea Biopharmaceuticals, Inc.

NYSE American: NAVB

Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) is a biopharmaceutical company focused on the development of precision immunodiagnostic agents and immunotherapeutics.

Thursday, October 29   |   10:00 AM ET

Outlook Therapeutics, Inc.

NASDAQ: OTLK
Outlook_Logo.png

Outlook Therapeutics is a late clinical-stage biopharmaceutical company working to develop ONS-5010 / LYTENAVA™ (bevacizumab-vikg) as the first FDA-approved ophthalmic formulation of bevacizumab-vikg for use in retinal indications, including wet AMD, DME and BRVO.

Thursday, October 29   |   2:00 PM ET

Evofem Biosciences, Inc.

NASDAQ: EVFM

Evofem Biosciences, Inc., (NASDAQ: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs).

Evofem_Logo.png
© 2020 Virtual Investor. All rights reserved.

Wednesday, October 28   |   10:00 AM ET

Protalix BioTherapeutics, Inc.

NYSE American: PLX, TASE: PLX

Protalix is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell-based expression system, ProCellEx®.

Protalix_banner.png